Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia

Pain Medicine : the Official Journal of the American Academy of Pain Medicine
Hsu-Tang LiuJenkin S Hu

Abstract

Botulinum toxin type A (BTX-A) has been widely used in many clinical disorders including migraine, cervical dystonia, etc. The use of BTX-A in neuropathic pain, however, is uncommon, and the application of the anti-nociceptive effect of botulinum toxin is emerging. Here we report a case of an 80-year-old man who suffered from severe pain of post-herpetic neuralgia which was refractory to the usual therapies. However, this neuropathic pain was dramatically relieved by multiple BTX-A injection and the pain relief lasted 52 days.

References

Nov 1, 1996·Pain·F Cervero, J M Laird
Nov 8, 2001·Experimental Cell Research·J C Hay
Feb 7, 2003·The Clinical Journal of Pain·Joseph C Arezzo
Feb 7, 2003·The Clinical Journal of Pain·Charles E Argoff
Jul 23, 2003·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Bahman JabbariMarc P Difazio
Sep 23, 2003·Anesthesia and Analgesia·Andrei B PetrenkoKoki Shimoji

❮ Previous
Next ❯

Citations

Mar 20, 2014·Pain Management·E Alexandra BrownDavid M Simpson
Jun 2, 2011·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Ian CarrollSean Mackey
Mar 10, 2010·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Seung Hyun YoonSeong Taek Kim
Aug 20, 2015·Toxins·Hyun-Mi Oh, Myung Eun Chung
Oct 13, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Hollis E KrugMaren L Mahowald
Dec 8, 2010·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Charles Argoff
Nov 8, 2007·Pain Practice : the Official Journal of World Institute of Pain·Leonardo KapuralNagy Mekhail
May 28, 2008·Pain Practice : the Official Journal of World Institute of Pain·Louise C Jeynes, Charles A Gauci
Jun 12, 2008·Annals of Neurology·Danièle RanouxD Bouhassira
Jun 22, 2012·Pain Practice : the Official Journal of World Institute of Pain·Gustavo FabregatJosé De Andrés
May 14, 2014·British Journal of Pharmacology·Roshni Ramachandran, Tony L Yaksh
Jan 28, 2016·Annals of Neurology·Zee-A HanMyung Eun Chung
May 11, 2015·Neurobiology of Disease·Roshni RamachandranTony L Yaksh
Jul 16, 2016·Journal of Dental Research·K Y YangD K Ahn
Aug 25, 2017·Toxins·JungHyun Park, Hue Jung Park
Jan 23, 2018·Annals of Rehabilitation Medicine·Kyung Eun NamSeong Hoon Lim
Aug 25, 2016·Plastic and Reconstructive Surgery·Marie E NolandRod J Rohrich
Jun 27, 2020·Plastic and Reconstructive Surgery·Matthew D FreemanPeter J Taub
Aug 28, 2020·Frontiers in Neurology·Gabriella EgeoPiero Barbanti
Aug 31, 2018·Neuronal Signaling·Raj Kumar
Dec 8, 2016·Der Nervenarzt·L HalbH Bornemann-Cimenti
Jul 12, 2020·American Journal of Clinical Dermatology·Tina S Alster, Iris S Harrison
Feb 11, 2021·Toxins·Emanuela MartinaAnnamaria Offidani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.